ABOUT US | CONTACT | IAPAC HOME 
 

ABOUT ATLIS

ATLIS PRESS RELEASE
ATLIS KEY FINDINGS

ATLIS FINDINGS

GENERAL HEALTH STATUS
CURRENT AND FUTURE MEDICATIONS
PRIORITIES FOR FUTURE MEDICATIONS
CONCERNS ABOUT HIV STATUS
CURRENT SEX PRACTICES

Most desired traits in future HIV medications
(Ranked from 1 to 7, lower average rank indicates a higher desire)
(click here to downlaod PDF tables)

Region

Country

Easier to take

Help
me live
longer

Fewer side effects

More affordable

Attack virus in
new
way

Would
not have
to take
for rest
of life

Better access

 

 

Average Rank

Average Rank

Average Rank

Average Rank

Average Rank

Average Rank

Average Rank

Western Europe
and USA

France

4.4

2.8

3.4

5.5

3.8

3.3

4.8

Germany

4.8

2.1

3.2

5.3

3.9

3.7

5.0

Italy

3.7

2.0

2.9

5.5

4.6

3.6

5.7

Spain

3.4

2.2

2.6

5.6

3.8

5.5

5.0

USA

4.9

2.9

3.8

4.5

4.0

2.9

5.1

Latin America

Caribbean

3.2

3.1

3.5

4.3

4.6

4.3

5.0

Mexico

4.0

2.9

3.6

4.3

4.7

4.1

4.5

Argentina

4.1

2.7

3.2

5.7

4.0

3.8

4.6

Brazil

3.9

2.8

3.3

5.3

4.5

3.4

4.9

South Africa, Russia, Asia/
Pacific

South Africa

3.9

2.9

3.8

4.8

4.0

3.8

4.8

Russia

3.4

2.9

3.1

5.4

4.5

3.1

5.6

Korea

3.8

3.8

3.7

4.7

4.6

2.4

5.1

Malaysia

4.4

3.8

4.0

4.9

3.9

3.3

3.7

New Zealand

4.5

3.2

3.6

5.3

3.9

3.4

4.1

 
line
©2008 International Association of Physicians in AIDS Care. All Rights Reserved.